ALADDIN HLTHC.TECH. O.N. news, videos and press releases
For more news please use our advanced search feature.
ALADDIN HLTHC.TECH. O.N. - More news...
ALADDIN HLTHC.TECH. O.N. - More news...
- DGAP-Adhoc: Aladdin Healthcare Technologies SE: Notice of fine by BaFin in the total amount of approximately EUR 155,000
- DGAP-News: Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA
- DGAP-News: Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis
- DGAP-Adhoc: Aladdin Healthcare Technologies SE reports the sale of software and intellectual property
- DGAP-News: Aladdin Healthcare Technologies starts OTC Entry Level Listing in the USA and looks forward to further expansion
- DGAP-News: Aladdin Healthcare Technologies jointly develops AI-Platform for Cardiovascular Diseases that achieves three Patents in China
- DGAP-News: Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof
- DGAP-Adhoc: Aladdin Healthcare Technologies SE reports preliminary figures for financial year 2019 and readjustment of the 2018 financial year figures
- DGAP-News: Aladdin Healthcare Technologies discovers anti-osteoporosis nanomolar activity leads from natural compounds dataset with its Deep Learning Algorithms for drug discovery, validated by leading scientific publication 'European Journal of Medicinal Chemistry'
- DGAP-News: Aladdin Healthcare Technologies completes AI-driven Drug Discovery Platform (AIDD) for Commercial Use in Drug Development
- DGAP-News: Aladdin Healthcare Technologies will obtain an equity stake in public spinoff No-Age Biotech Inc. at TSX, aimed to combat age-related diseases
- DGAP-News: Aladdin Healthcare Technologies completes Biomedical Knowledge Graph for Commercial use In Drug Development
- DGAP-News: Aladdin Healthcare Technologies signs with leading Market Maker and Broker for OTCQX Listing in the USA
- DGAP-News: Aladdin Healthcare Technologies achieves OTCQX listing in the USA
- DGAP-News: Aladdin Healthcare Technologies validates its proprietary Deep Learning Algorithms that significantly improve Drug Discovery Performance
- DGAP-News: Aladdin Healthcare Technologies becomes a sponsor of University College London's (UCL) Industry Exchange Network (IXN) Programme
- DGAP-News: Aladdin Healthcare Technologies develops fully automated deep learning process to detect and distinguish COVID-19 from other diseases from CT images /research study published on IEEE Access
- DGAP-News: Aladdin Healthcare Technologies SE discovers Life-Saving Drug Repurposed for Coronavirus and wins the World's Leading Data Mining Conference Cup
- DGAP-News: Aladdin Healthcare Technologies SE takes another big step forward in early diagnosis of Alzheimer's Disease: Aladdin gets extensive multimodal data from the largest Dementia platform in the UK
- DGAP-News: Aladdin Healthcare Technologies SE achieves milestone in drug development against Alzheimer's and other age-related diseases: new compounds discovered through self-developed AI Virtual Screen with Recommendation Success Rate 40 times higher than tradition
- DGAP-News: Aladdin Healthcare Technologies SE achieves further milestone in COVID-19 drug development: Discovery of 20 new optimized compounds with AI DD platform
- DGAP-News: Aladdin Healthcare Technologies SE wins EUR 1.4 million EU grant with large-scale project 'Dragon' for Coronavirus diagnostics
- DGAP-News: Aladdin Healthcare Technologies SE promotes drug development with Joint Venture in China - first sales revenues of EUR 120.000 generated
- DGAP-Adhoc: Aladdin Healthcare Technologies sets up Joint Venture with Chinese partner network and wins new customer - first sales revenues of EUR 120,000
- DGAP-News: Aladdin Healthcare Technologies SE has launched its Health Risk Assessment Tool to Airbus (India) and Saregama (India)
- DGAP-News: Aladdin Healthcare Technologies SE: Aladdin Healthcare Technologies SE Q1-Performance Review: Breakthrough for faster Drug Development and successful implementation of AI tools against the spread of COVID-19 - Benchmark of Business Plan exceeded
- DGAP-Adhoc: Aladdin Healthcare Technologies SE: Capital increase against cash contribution with subscription rights and public offer
- DGAP-News: Aladdin Healthcare Technologies SE launches its prototype 'Health Risk Assessment Tool' for COVID-19 in India - The Technology is the basis for worldwide application
